Jeffrey S. Aronin is chairman and CEO of Paragon Biosciences, which he founded in 2017. Aronin is a bioscience entrepreneur known for innovating, developing, and commercializing a record number of novel neurology medicines that improve the lives of patients. Paragon Biosciences creates, builds, and funds companies focused on advanced biotechnology and gene therapy. Its current portfolio of companies includes Harmony Biosciences, CiRC Biosciences, Emalex Biosciences, Evozyne, and several early-stage businesses. Aronin serves on corporate and civic boards including Discover Financial Services, the Aspen Institute, and the International Board of the Weizmann Institute of Science.